trastuzumab deruxtecan,ruxolitinib
novartis,daiichi sankyo,astrazeneca,incyte
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rux,(-crux),(-trux)', 'destiny,crc,02', 'trastuzumab deruxtecan']
destiny -crc02 trastuzumab deruxtecan in crc . for both k ras mutated and wild type .
5.4 mg per kg dose better tolerated will it make it big in crc ? #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists